As of June 8, 2021, China has reported a cumulative total of 809 million doses of Covid-19 vaccines, People's Daily reported Wednesday.
That's just five days after the figure reached 700 million and 74 days after vaccinations exceeded the 100 million dose threshold on March 27.
Notably, a new Covid-19 vaccine, developed by the Institute of Medicinal Biotechnology Chinese Academy of Medical Sciences, received an emergency use authorization on June 9, which is expected to accelerate the pace of vaccination in China.
On June 6, China expanded the age range for emergency use of the Covid-19 vaccine to 3 years and older.
Previously, China's new Covid-19 vaccine was available for people over the age of 18, with the maximum age of vaccine recipients exceeding 100 years old.
At the end of May, the Chinese Center for Disease Control and Prevention released data showing that as of April 30, China had reported 265 million doses of Covid-19 vaccines and 31,434 adverse reactions.
This represents an adverse reaction rate of 11.86 percent per 100,000 doses, which is lower than the average reported for all other types of vaccines in China in 2019.
